Companies

See how salaries can vary from company to company

Tyme Technologies, Inc., a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York. view company details

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Its therapeutic candidates include luspatercept, which completed Phase III clinical trials for the treatment of myelodysplastic syndromes, beta-thalassemia, and myelofibrosis; Phase II clinical trials for the treatment of patients with transfusion-dependent beta-thalassemia. The company is also developing and sotatercept for the treatment of patients with pulmonary hypertension. In addition, the company is developing... view company details

Humanigen, Inc., a biopharmaceutical company, develops proprietary monoclonal antibodies for immunotherapy and oncology treatments. The company's lead product candidate is Lenzilumab, a monoclonal antibody that targets and neutralizes granulocyte-macrophage colony-stimulating factor, which is in Phase I/II clinical trial in patients with chronic myelomonocytic leukemia, and for the treatment of juvenile myelomonocytic leukemia. It also develops Ifabotuzumab, a monoclonal antibody that targets EphA3 receptor, which has completed the Phase I dose escalation portion of a Phase I/II clinical trial... view company details

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company is involved in developing sitravatinib, a spectrum-selective kinase inhibitor, which is in Phase II clinical for the treatment of non-small cell lung cancer (NCSLC); and in Phase Ib clinical trial to treat NCSLC patients with Casitas B-lineage Lymphoma genetic alterations, as well as KRAS G12C inhibitor program for NSCLC adenocarcinoma patients, colorectal cancer patients, and other cancers. It also develops moc... view company details

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Its MultiTAA T cell technology is based on the tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. The company is developing TPIV100/110, which is in Phase II clinical trial to treat human epidermal growth factor receptor 2 breast cancer; and TPIV200 that is in Phase II clinical trial for the treatment of ... view company details

BTM Global provides retail system integration and development services for clients ranging from small regional chains to the world's most recognized brands. Through strategy, development, implementation and support, we approach each project as a partnership that helps clients become more seamless, efficient and profitable. Our teams are made up of strategic advisors, problem solvers and proactive partners who examine a project from many angles and perspectives to offer the best solution to a client's challenges. view company details

Daybreak Oil and Gas, Inc. operates as an independent crude oil and natural gas exploration, development, and production company in the United States. It holds interests in the East Slopes project located in the southeastern part of the San Joaquin Basin near Bakersfield, California. The company also holds a 30% working interest in the Michigan Basin project covering 1,400 acres area. As of February 28, 2018, it had estimated proved reserves of 428,067 barrels of oil equivalent. The company was formerly known as Daybreak Mines, Inc. and changed its name to Daybreak Oil and Gas, Inc. in October... view company details

LRAD Corporation designs, develops, and commercializes directed and multidirectional sound technologies in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers voice broadcast products; and location-based mass messaging solutions for emergency warning and workforce management. The company also provides acoustic hailing devices that is used to broadcast project audible voice and tone; and Genasys mass notification that is used to broadcast project audible voice. It sells its products directly to governments, militaries, end-users, and defense-related companies. The com... view company details

Paramount Gold Nevada Corp., together with its subsidiaries, acquires, explores, and develops precious metal properties in the United States. The company primarily explores for gold and silver ores. Its principal property is the Sleeper gold project that comprises 2,322 unpatented mining claims totaling approximately 38,300 acres located in Humbolt County, Nevada. The company also owns Grassy Mountain project that consists of 418 unpatented lode claims, 3 patented lode claims, 9 mill site claims, and 6 association placer claims covering approximately 9,300 acres located in Malheur County, Oreg... view company details

Raken is a cloud-based, mobile, daily reporting and field management platform for contractors. We enable superintendents, foreman and project managers to streamline field workflows by creating accurate daily reports, time cards, and more in less time. We work with commercial, residential, and specialty contractors of all shapes and sizes. Raken's digital toolbox allows you to manage/document accidents & delays, subcontractor information, site safety & quality control observations, project photos, weather, task lists, equipment rental, jobsite visitors, time cards, and more! view company details

Texas Mineral Resources Corp., an exploration stage mining company, acquires, explores, and develops mineral properties in the United States. It primarily holds interests in the Round Top rare earth-uranium-beryllium project covering 950 acres in Hudspeth County, Texas; and prospecting permits covering 9,345 acres adjacent to the Round Top project. The company was formerly known as Texas Rare Earth Resources Corp. and changed its name to Texas Mineral Resources Corp. in March 2016. Texas Mineral Resources Corp. was incorporated in 1970 and is headquartered in Sierra Blanca, Texas. view company details

Uranium Energy Corp. engages in exploration, pre-extraction, extraction, and processing uranium and titanium concentrates in the United States, Canada, and Paraguay. It owns interests in the Palangana mine, Burke Hollow, Goliad, Longhorn, and Salvo projects located in Texas; Anderson, Workman Creek, and Los Cuatros projects situated in Arizona; Slick Rock project in Colorado; Diabase project located in Canada; and Yuty, Oviedo, and Alto Parana titanium projects in Paraguay. The company was formerly known as Carlin Gold Inc. and changed its name to Uranium Energy Corp. in January 2005. Uranium ... view company details

Viking Automatic Sprinkler Co., specializing in fire protection since 1924, offers fire protection systems and services to customers throughout the US. Viking handles all phases of fire protection, including engineering and design, project management, installation, inspection, repair and maintenance. The qualified professionals at Viking recognize that each customer has unique needs. Regulatory codes, insurance specifications, environmental and operational concerns are routinely balanced within budget parameters. In-house staff of CAD based engineering technicians, project managers, and experi... view company details

ENGlobal Corporation provides engineering and professional services primarily to the energy industry in the United States and internationally. The company operates through two segments, Engineering, Procurement and Construction Management (EPCM); and Automation. The EPCM segment offers services relating to the development, management, and execution of projects requiring professional engineering and related project management services primarily to the energy industry, which include conceptual studies, project definition, cost estimating, engineering design, environmental compliance, material pr... view company details

KDG Construction Consulting is a leading provider of program, project and construction management services. The firm serves clients in a broad range of markets throughout Southern California, including aviation, utilities, government and affordable housing. KDG provides a full spectrum of management and technical services spanning the entire lifecycle of a construction project. For nearly 30 years, KDG has partnered with public agencies, private corporations and non-profit organizations to successfully deliver a broad range of projects, ranging from $5-$200M in value, throughout Southern Calif... view company details

OSC was founded in 1991 by Randy O'Donnell and Trey Snider, industry peers who created a construction firm focused on customer service, quality and respect. Today our values remain the same. Our firm has grown steadily, increasing our staff, market sectors served, and our geographic reach, to align with our customer's needs. We are proactive construction partners that consistently deliver outstanding results. We are leaders in the industry utilizing technologies that deliver value and further transparent communication. We understand that each finished project represents significant levels of c... view company details

Halozyme Therapeutics, Inc., a biotechnology company, engages in researching, developing, and commercializing novel oncology therapies in the United States, Switzerland, and internationally. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other drugs or can be used to alter tissue structures for clinical benefit. The company's products are based on the Enhanze technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal ... view company details

Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company markets OMIDRIA for use in cataract surgery or intraocular lens replacement in the United States. Its clinical programs include OMS721 that is in Phase III clinical trial for treating immunoglobulin A (IgA) nephropathy, hematopoietic stem cell transplant-associated thrombotic microangiopathy (HCT-TMA), and atypical hemolytic uremic syndrome (aHUS);... view company details

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. The company's lead product candidates include entinostat, which is in Phase III clinical trials for the treatment of advanced hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) breast cancer; and SNDX-5613 inhibitor that targets the binding interaction of Menin with mixed lineage leukemia-rearranged and acute myeloid leukemia with a mutated nucleophosmin 1. It also develops entinostat with Keytruda (pembrolizumab) in a Phase Ib/II ... view company details

Neuralstem, Inc., a clinical stage biopharmaceutical company, focuses on the research and development of nervous system therapies based on its proprietary human neuronal stem cells and small molecule compounds. The company's stem cell based technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types. Its lead product candidate is NSI-189, a chemical entity, which has been completed Phase II clinical trial for the treatment of major de... view company details